Sana Biotechnology, Inc. - Common Stock — Cash Flow (NASDAQ:SANA) | MetaTrader

Open full chart

Financials

Overview Statement Statistics Documents

Quarterly Annual

Cash from operating activities -251.05 M-290.05 M-253.58 M-223.15 M-143.83 M -132.24 M Cash from investing activities -245.8 M210.56 M172.01 M17.45 M-40.24 M -102.6 M Cash from financing activities 631.75 M4.91 M31.65 M199.75 M128.73 M 220.64 M Free cash flow -251.05 M-290.05 M-253.58 M-223.15 M-144.77 M -135.06 M

News

Sana Biotechnology: Promising Science, But Dilution Keeps The Rating A Hold (NASDAQ:SANA)

Sana Biotechnology: A $1 Billion Market Cap Built On A Pre-Phase 1 Foundation (SANA)

3 Promising Genomics Stocks to Add to Your Portfolio in 2026

Sana (SANA) Upgraded to Buy: Here's What You Should Know

Sana Biotechnology, Inc. (SANA) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

Sana Biotechnology, Inc. (SANA) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Sana Biotechnology: Mayo Clinic Deal A Positive Step On A Long Journey (NASDAQ:SANA)

H.C. Wainwright reiterates Sana Biotechnology stock buy rating

Morgan Stanley reiterates Sana Biotechnology stock rating on diabetes data

Sana Biotechnology reports 14-month data on diabetes cell therapy

Sana Biotechnology, Inc. (SANA) Presents at TD Cowen 46th Annual Health Care Conference Transcript

TD Cowen reiterates Buy rating on Sana Biotechnology stock